Luoxin Pharmaceuticals Group Stock Co Ltd (002793) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.059x

Based on the latest financial reports, Luoxin Pharmaceuticals Group Stock Co Ltd (002793) has a cash flow conversion efficiency ratio of 0.059x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥90.75 Million ≈ $13.28 Million USD) by net assets (CN¥1.53 Billion ≈ $223.90 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 002793 company net worth for the company's overall valuation and market capitalisation.

Luoxin Pharmaceuticals Group Stock Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Luoxin Pharmaceuticals Group Stock Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Luoxin Pharmaceuticals Group Stock Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Luoxin Pharmaceuticals Group Stock Co Ltd ranked by their cash flow conversion efficiency. Explore 002793 operating cash flow to net income to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Northern Dynasty Minerals Ltd TO:NDM	-0.089x
Shenzhen Grandland Decoration Group Co Ltd SHE:002482	0.133x
Mrs. Bectors Food Specialities Limited NSE:BECTORFOOD	0.084x
Zhejiang Founder Motor Co Ltd SHE:002196	0.024x
Bank Artos Indonesia Tbk PT JK:ARTO	0.035x
Gilat Satellite Networks Ltd NASDAQ:GILT	-0.004x
Beijing Utour International Travel Service Co Ltd SHE:002707	0.167x
Fidus Investment Corp NASDAQ:FDUS	0.018x

Annual Cash Flow Conversion Efficiency for Luoxin Pharmaceuticals Group Stock Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Luoxin Pharmaceuticals Group Stock Co Ltd from 2011 to 2025. View today's stock price for Luoxin Pharmaceuticals Group Stock Co Lt for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.24 Billion ≈ $180.82 Million	CN¥253.07 Million ≈ $37.03 Million	0.205x	+289.35%
2024-12-31	CN¥1.46 Billion ≈ $213.56 Million	CN¥-157.85 Million ≈ $-23.10 Million	-0.108x	-150.33%
2023-12-31	CN¥2.57 Billion ≈ $376.42 Million	CN¥552.79 Million ≈ $80.89 Million	0.215x	+175.66%
2022-12-31	CN¥3.31 Billion ≈ $483.84 Million	CN¥-939.13 Million ≈ $-137.42 Million	-0.284x	-1215.03%
2021-12-31	CN¥4.74 Billion ≈ $692.99 Million	CN¥120.63 Million ≈ $17.65 Million	0.025x	+442.04%
2020-12-31	CN¥4.35 Billion ≈ $636.59 Million	CN¥-32.40 Million ≈ $-4.74 Million	-0.007x	-125.36%
2019-12-31	CN¥3.96 Billion ≈ $579.73 Million	CN¥116.33 Million ≈ $17.02 Million	0.029x	-76.59%
2018-12-31	CN¥909.89 Million ≈ $133.14 Million	CN¥114.12 Million ≈ $16.70 Million	0.125x	-7.52%
2017-12-31	CN¥754.19 Million ≈ $110.36 Million	CN¥102.27 Million ≈ $14.97 Million	0.136x	+30.19%
2016-12-31	CN¥698.33 Million ≈ $102.19 Million	CN¥72.74 Million ≈ $10.64 Million	0.104x	-39.16%
2015-12-31	CN¥339.50 Million ≈ $49.68 Million	CN¥58.12 Million ≈ $8.51 Million	0.171x	+29.11%
2014-12-31	CN¥315.46 Million ≈ $46.16 Million	CN¥41.83 Million ≈ $6.12 Million	0.133x	-48.50%
2013-12-31	CN¥251.50 Million ≈ $36.80 Million	CN¥64.75 Million ≈ $9.48 Million	0.257x	+58.84%
2012-12-31	CN¥205.54 Million ≈ $30.08 Million	CN¥33.31 Million ≈ $4.88 Million	0.162x	-47.10%
2011-12-31	CN¥151.87 Million ≈ $22.22 Million	CN¥46.53 Million ≈ $6.81 Million	0.306x	--

About Luoxin Pharmaceuticals Group Stock Co Ltd

SHE:002793 China Drug Manufacturers - Specialty & Generic

Market Cap

$735.27 Million

CN¥5.02 Billion CNY

Market Cap Rank

#10398 Global

#2805 in China

Share Price

CN¥4.62

Change (1 day)

+2.21%

52-Week Range

CN¥3.80 - CN¥5.77

All Time High

CN¥25.07